Article
Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
Stroke - 1 Oct 1996
Deschiens M A, Conard J, Horellou M H, Ameri A, Preter M, Chedru F, Samama M M, Bousser M G
Abstract excerpt
BACKGROUND AND PURPOSE: Cerebral venous thrombosis (CVT) is an infrequent condition with a large variety of causes. However, in 20% to 35% of cases, no cause is found. We studied coagulation parameters, including activated protein C resistance associated with factor V gene mutation (factor V Leiden) and anticardiolipin antibodies, in a large series of patients with CVT with or without identified cause or risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.